Unknown

Dataset Information

Clozapine as a Model for Antipsychotic Development.


ABSTRACT: Schizophrenia is a devastating illness that affects up to 1% of the population; it is characterized by a combination of positive symptoms, negative symptoms, and cognitive impairment. Currently, treatment consists of one class of medications known as antipsychotics, which include typical (first-generation) and atypical (second-generation) agents. Unfortunately, antipsychotic medications have limited efficacy, with up to a third of patients lacking a full response. Clozapine, the first atypical antipsychotic developed, is the only medication shown to be superior to all other antipsychotics. However, owing to several life-threatening side effects and required enrollment in a registry with routine blood monitoring, clozapine is greatly underutilized in the US. Developing a medication as effic

SUBMITTER: Nucifora FC 

PROVIDER: S-EPMC5509641 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature